EUVIMEDEUVIMED entdecken
Crossref

ChREBP deficiency aggravates diabetic sarcopenia by disrupting glucose signaling: a novel mouse model of muscle atrophy

Toshinori Imaizumi iD, Katsumi Iizuka iD, Hiromi Tsuchida iD, Mayu Sakai iD, Sodai Kubota iD, Saki Kubota-Okamoto iD, Yoshihiro Takahashi iD, Ken Takao iD, Takehiro Kato iD, Masami Mizuno iD, Takuo Hirota iD, Yukio Horikawa iD und 3 weitere

Journal of Endocrinology · 2026

DOI: 10.1530/joe-25-0257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinology, 2026. Verfasst von Toshinori Imaizumi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology and Metabolism/Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine,…. Hauptthemen laut MEDLINE: Sarcopenia, Glucose, Muscular Atrophy, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Association for Diabetes Education and Care.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes is an increasingly prevalent global disease and is often accompanied by sarcopenia, particularly in older adults. While insulin resistance is a well-known contributor to muscle loss in diabetes, the role of glucose signaling in diabetic skeletal muscle atrophy, particularly under insulin-deficient conditions, remains poorly understood. This study aimed to elucidate the pathophysiological role of the carbohydrate-responsive element-binding protein (ChREBP), a glucose-sensing transcription factor encoded by the Chrebp gene in mice, in diabetic sarcopenia by generating Chrebp-deficient, insulin-deficient Ins2Akita/+ mice. We evaluated Chrebp+/+, Chrebp−/−, Ins2Akita/+/Chrebp+/+, and Ins2Akita/+/Chrebp−/− mice for muscle strength, endurance, survival, body composition, and muscle histology. Skeletal muscles were analyzed for gene expressions related to anabolic and catabolic pathways. We found that Ins2Akita/+/Chrebp−/− mice exhibited significant reductions in body weight, grip strength, survival, and skeletal muscle mass – particularly in the tibialis anterior, soleus, gastrocnemius, and quadriceps – compared to Ins2Akita/+ controls, despite similar hyperglycemia. Histological analysis revealed a smaller mean muscle fiber size and reduced cross-sectional area of type 2A and 2B fibers, without changes in fiber-type composition. Furthermore, Igf-1 expression was suppressed, while the atrophy marker Fbxo32/Atrogin-1 was upregulated. These findings demonstrate that Chrebp deletion exacerbates muscle atrophy and frailty in insulin-deficient mice, underscoring a key role for ChREBP-mediated glucose signaling in maintaining muscle mass under diabetic conditions. The Ins2Akita/+/Chrebp−/− model provides a valuable platform for exploring diabetic sarcopenia mechanisms and potential therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaGlucoseMuscular AtrophyBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsTranscription FactorsDiabetes Mellitus, ExperimentalAnimalsMiceMuscle, SkeletalSignal TransductionDisease Models, AnimalMaleMice, KnockoutInsulinMuscle Strength

Stichwörter der Autor:innen

carbohydrate-responsive element-binding proteindiabetesmuscle massmuscle strengthsarcopenia

Substanzen

Mlxipl protein, mouseGlucoseBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsTranscription FactorsInsulin

Autor:innen und Institutionen

  • Department of Diabetes, Endocrinology and Metabolism/Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Departments of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Clinical Nutrition, Fujita Health University, Toyoake, Japan.
  • Center for One Medicine Innovative Translational Research, Gifu University Institute of Advanced Studies, Gifu, Japan.

ORCID-Profile: Toshinori Imaizumi, Katsumi Iizuka, Hiromi Tsuchida, Mayu Sakai, Sodai Kubota, Saki Kubota-Okamoto, Yoshihiro Takahashi, Ken Takao, Takehiro Kato, Masami Mizuno, Takuo Hirota, Yukio Horikawa, Shin Tsunekawa, Takaaki Murakami, Daisuke Yabe

Förderung

  • Japan Society for the Promotion of Science, Japan Association for Diabetes Education and Care

Zitieren

APA

Imaizumi, T., Iizuka, K., Tsuchida, H., Sakai, M., Kubota, S., Kubota-Okamoto, S., Takahashi, Y., Takao, K., Kato, T., Mizuno, M., Hirota, T., Horikawa, Y., Tsunekawa, S., Murakami, T., & Yabe, D. (2026). ChREBP deficiency aggravates diabetic sarcopenia by disrupting glucose signaling: a novel mouse model of muscle atrophy. Journal of Endocrinology. https://doi.org/10.1530/joe-25-0257

Vancouver

Imaizumi T, Iizuka K, Tsuchida H, Sakai M, Kubota S, Kubota-Okamoto S, et al. ChREBP deficiency aggravates diabetic sarcopenia by disrupting glucose signaling: a novel mouse model of muscle atrophy. Journal of Endocrinology. 2026. doi:10.1530/joe-25-0257

BibTeX
@article{Imaizumi2026,
  author = {Imaizumi, Toshinori and Iizuka, Katsumi and Tsuchida, Hiromi and Sakai, Mayu and Kubota, Sodai and Kubota-Okamoto, Saki and Takahashi, Yoshihiro and Takao, Ken and Kato, Takehiro and Mizuno, Masami and Hirota, Takuo and Horikawa, Yukio and Tsunekawa, Shin and Murakami, Takaaki and Yabe, Daisuke},
  title = {ChREBP deficiency aggravates diabetic sarcopenia by disrupting glucose signaling: a novel mouse model of muscle atrophy},
  journal = {Journal of Endocrinology},
  year = {2026},
  doi = {10.1530/joe-25-0257}
}
Kostenlos starten →